Drug Discovery 2017
Poster
28

Fragment screening against the lysine methyltransferase G9a using Microscale Thermophoresis

Objective

Fragment-based lead discovery (FBLD) has become widely used as an alternative to traditional high throughput screening (HTS).  As fragment hits have relatively weak affinity, they are often identified using biophysical techniques such as NMR, SPR, DSF, ITC, or X-ray crystallography. A new technique, Microscale Thermophoresis (MST), is well suited to characterising the binding of fragments - or even ions - to biomolecules due to its large detection range from pM to mM affinities. MST measures the movement of fluorescently-labelled molecules in temperature gradients created by laser within microliter-volume glass capillaries. The thermophoretic movement of a molecule is determined by its size, charge, and hydration shell. Ligand binding affects these properties, resulting in changes in the thermophoretic characteristics of the molecule. These changes can be used to derive dissociation constants (Kd).  This method offers a number of benefits for FBLD, notably its fast, efficient and precise ability to characterise fragments with a low number of false positives and false negatives, whilst using very small amounts of protein.

Here, we report an affinity-based FBLD approach using MST to screen a library of 320 fragments against histone-lysine methyltransferase G9a (also known as EHMT2).

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2038